1 We investigated how manipulations of the degree of activation of adenosine A 1 and A 2A receptors in¯uences the action of the neuropeptide, calcitonin gene-related peptide (CGRP) on synaptic transmission in hippocampal slices. Field excitatory post-synaptic potentials (EPSPs) from the CA1 area were recorded. 2 When applied alone, CGRP (1 ± 30 nM) was without eect on ®eld EPSPs. However, CGRP (10 ± 30 nM) signi®cantly increased the ®eld EPSP slope when applied to hippocampal slices in the presence of the A 1 receptor antagonist, 1,3-dipropyl-8-cyclopenthyl xanthine (DPCPX, 10 nM), or in the presence of the A 2A adenosine receptor agonist CGS 21680 (10 nM). 3 The A 2A receptor antagonist, ZM 241385 (10 nM) as well as adenosine deaminase (ADA, 2 U ml 71 ), prevented the enhancement of ®eld EPSP slope caused by CGRP (30 nM) in the presence of DPCPX (10 nM), suggesting that this eect of CGRP requires the concomitant activation of A 2A adenosine receptors by endogenous adenosine. 4 The protein kinase-A inhibitors, N-(2-guanidinoethyl)-5-isoquinolinesulfonamide (HA-1004, 10 mM) and adenosine 3',5'-cyclic monophosphorothioate, Rp-isomer (Rp-cAMPS, 50 mM), as well as the inhibitor of ATP-sensitive potassium (K ATP ) channels, glibenclamide (30 mM), prevented the facilitation of synaptic transmission caused by CGRP (30 nM) in the presence of DPCPX (10 nM), suggesting that this eect of CGRP involves both K ATP channels and protein kinase-A. 5 It is concluded that the ability of CGRP to facilitate synaptic transmission in the CA1 area of the hippocampus is under tight control by adenosine, with tonic A 1 receptor activation by endogenous adenosine`braking' the action of CGRP, and the A 2A receptors triggering this action.
Introduction
Adenosine, by operating inhibitory A 1 receptors or excitatory A 2 receptors, has widespread modulatory actions in the nervous system (for a review see SebastiaÄ o & Ribeiro, 1996) and may interfere with the action of other neuromodulator/ neurotransmitter substances (Ribeiro, 1999) . Of particular interest in the context of the present study are the evidences that A 2A receptor activation inhibits A 1 receptor function in the hippocampus (Cunha et al., 1994) and that tonic activation of adenosine A 2A receptors facilitates the action of other neuromodulators, such as that of the neuropeptide calcitonin gene-related peptide (CGRP) at motor nerve terminals (Correia-de-SaÂ & Ribeiro, 1994) . Adenosine, through A 1 receptor activation, may also interfere with CGRP release (Santicioli et al., 1993) .
CGRP is a 37-amino acid peptide generated from the calcitonin gene by alternate tissue-speci®c splicing (Amara et al., 1982) . It is widely present in the peripheral and in the central nervous system (for reviews see Ishida-Yamamoto & Tohyama, 1989; Poyner, 1992) , including the hippocampus (Bulloch et al., 1996; Freund et al., 1997; Oliver et al., 1999) , where it inhibits NMDA receptor-mediated actions (Bouchard et al., 1995) and may protect against injury (Bulloch et al., 1996; .
The present work was designed to investigate how manipulations of the degree of activation of adenosine A 1 and A 2A receptors in¯uences the action of CGRP on synaptic transmission in the hippocampus. Since the predominant action of endogenous adenosine on synaptic transmission in the hippocampus is inhibitory, through A 1 receptor activation (e.g. Dunwiddie & Diao, 1994) , we ®rst evaluated how blockade of A 1 receptors could in¯uence the action of CGRP. Because synaptic transmission in the hippocampus can be in¯uenced by both inhibitory A 1 (SebastiaÄ o et al., 1990) and excitatory A 2A (SebastiaÄ o & Ribeiro, 1992) adenosine receptors, we then investigated how the simultaneous blockade of these two adenosine receptor subtypes, and how removal of endogenous extracellular adenosine with adenosine deaminase, could in¯uence the eect of CGRP. How A 2A adenosine receptor activation by a selective agonist interferes with the action of CGRP on hippocampal synaptic transmission, was also evaluated. Since several CGRP-mediated action involve activation of protein-kinase A and of ATP-sensitive potassium channels (K ATP channels) (e.g. Zang et al., 1994; Santicioli & Maggi, 1994; Wellman et al., 1998) , we investigated how inhibition of PK-A with HA-1004 (Hidaka & Kobayahi, 1992) or with the cyclic AMP analogue, RpcAMPS (Rothermel & Parker-Bothelho, 1998 ) and how inhibition of K ATP channels with glibenclamide (Schmid-Antomarchi et al., 1987) aects the action of CGRP on synaptic transmission in the hippocampus.
A preliminary account of this study has been presented to the 6th International Symposium of Adenosine and Adenine Nucleotides, in Ferrara, Italy, May 1998 (SebastiaÄ o et al., 1998) and to the British Pharmacological Society (SebastiaÄ o et al., 1999) 
Methods
The experiments were performed on hippocampal slice preparations taken from male Wistar rats (5 ± 6 weeks old) handled according to the European Community guidelines on Animal Care. The animals were decapitated under halothane anaesthesia and the hippocampus dissected free into ice-cold Krebs solution of the following composition (mM): NaCl 124, KCl 3, NaH 2 PO 4 1.25, NaHCO 3 26, MgSO 4 1, CaCl 2 2, glucose 10, previously gassed with 95% O 2 /5% CO 2 (pH&7.4). Slices (400 mm thick) were cut perpendicular to the long axis of the hippocampus with a McIlwain tissue chopper, and allowed to recover for at least 1 h in a chamber within the same gassed medium at room temperature (22 ± 258C). A slice was then transferred to a 1 ml (plus 2 ml dead volume) recording chamber for submerged slices and continuously superfused with gassed bathing solution at 308C, at a¯ow rate of 3 ml min 71 . Drugs were added to this superfusion solution. Monopolar stimulation (rectangular pulse of 0.1 ms applied once every 10 s) was delivered through a concentric electrode placed on the Schaer collateral/commissural ®bres, in the stratum radium near the CA3/CA1 border. Evoked ®eld excitatory post-synaptic potentials (®eld EPSPs) were recorded through an extracellular electrode (4 M NaCl, 3 ± 5 MO resistance) placed in the stratum radiatum of the CA1 area. The intensity of the stimulus (80 ± 400 mA) was initially adjusted to obtain a large ®eld EPSP slope with a minimum population spike contamination. Recordings were obtained with an Axoclamp 2B ampli®er coupled to a DigiData 1200 interface (Axon Instruments). Averages of eight consecutive responses were continuously monitored on a personal computer with the LTP program (Anderson & Collingridge, 1997) , kindly supplied by W.W. Anderson (University of Bristol, U.K.). Responses were quanti®ed as the slope of the initial phase of the averaged ®eld EPSPs, since slope measures are considered a more accurate measure of ®eld EPSP magnitude than the amplitude, due to contamination by population spike.
To minimise underestimation of the CGRP responses due to desensitization (see Aiyar et al., 1992) , only one concentration of CGRP was applied to each slice, and thus, the concentration response curves showed in this paper were performed in a non-cumulative manner. CGRP was applied to each slice either alone or in the presence of adenosine receptor agonists and/or antagonists. Whenever the eect of CGRP was tested in the presence of other drugs, the neuropeptide was applied to the preparations only after a stable response to these drugs was observed and at least 20 min after starting their perfusion. Because CGRP is readily adsorbed onto plastic and glass, the chamber and all the connecting tubes were pretreated with Sigmacote to minimise losses of the peptide (see Afonso et al., 1996) . ). CGS 21680 and ZM 241385 was made up in 5 mM stock solutions in DMSO. CGRP was made up as a 1 mM stock solution in distilled water. Aliquots of the stock solutions were kept frozen at 7208C until use. In each experiment, one aliquot was thawed and diluted in Krebs solution.
Drugs

Analysis of the data
The data are expressed as means+s.e.mean from n number of slices. Unless otherwise stated, the signi®cance of the dierences between the means was evaluated by the Student's t-test. When comparing more than two experimental groups (Figure 3 ), one-way repeated measures ANOVA was used followed by the Newman-Keuls test. Values of P50.05 were considered to represent statistically signi®cant dierences.
Results
In¯uence of A 1 receptor blockade upon the eect of calcitonin gene-related peptide (CGRP) on hippocampal synaptic transmission
To prevent A 1 receptor activation by endogenous adenosine, we used the A 1 receptor antagonist, 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) at a concentration (10 nM) 20 times higher its anity value for the A 1 receptors in the hippocampus (see SebastiaÄ o et al., 1990) . At this concentration, DPCPX increased the slope of the ®eld EPSPs by 21+4.2% (n=20, P50.05), which is consistent with its ability to prevent the tonic inhibition of synaptic transmission caused by endogenous adenosine.
When applied to hippocampal slices in the absence of DPCPX, CGRP in low nanomolar concentrations (1 ± 30 nM) was virtually devoid of eect on the ®eld EPSPs. However, as illustrated in Figure 1 , when CGRP (30 nM) was applied to an hippocampal slice after a stable response to DPCPX was recorded, the neuropeptide caused a consistent and reversible increase (17+1.3%, n=19, P50.05) in the slope of the ®eld EPSPs. The maximal eect of the neuropeptide was obtained 15 ± 20 min after starting CGRP perfusion and was reversed within 15 ± 20 min after stopping CGRP perfusion (Figure 1 ).
In Figure 2 are compared the concentration-response curves for the eects of CGRP on the slope of ®eld EPSPs recorded in the absence and in the presence of DPCPX (10 nM). In the presence of this A 1 receptor antagonist, but not in its absence, CGRP concentration-dependently increased the slope of the ®eld EPSPs when tested in concentrations up to 30 nM. At an higher concentration (100 nM) CGRP inhibited the slope of the ®eld EPSPs by 15+6.2% (n=3), an action virtually not modi®ed when A 1 receptors were blocked by DPCPX (10 nM), the average inhibition caused by CGRP under this condition being 13+3.9% (n=3) (Figure 2) .
In¯uence of combined A 1 and A 2A adenosine receptors blockade, and of removal of endogenous adenosine, on the eect of CGRP on synaptic transmission
In a ®rst set of experiments we applied CGRP to hippocampal slices where A 1 and A 2A adenosine receptors have been blocked. To antagonize A 2A receptors we used the selective antagonist, ZM 241385, which has been shown to prevent adenosine A 2A receptor-mediated actions in the hippocampus (Cunha et al., 1997) ; CGRP was tested in the concentration (30 nM) that caused maximal enhancement of the ®eld EPSPs in the presence of DPCPX (10 nM). As illustrated in Figure 3A , CGRP (30 nM) was virtually devoid of eect on the ®eld EPSPs when applied to slices where both A 1 and A 2A adenosine receptors have been previously blocked with DPCPX (10 nM) and ZM 241385 (10 nM). By itself, ZM (10 nM), applied in the presence of DPCPX (10 nM), was virtually devoid of eect on the slope of EPSPs (per cent change of the ®eld EPSP slope: 0.2+2.5%, n=3), which con®rms previous observations (Cunha et al., 1997) . The simultaneous perfusion of ZM 241385 (10 nM) and DPCPX (10 nM) increased EPSP slope by 25+1.2% (n=3), an increase that was not signi®cantly dierent (P40.05) from that obtained (21+4.2%, n=20) with DPCPX (10 nM) alone.
In another set of experiments we applied the A 2A receptor antagonist only after the full excitatory action of CGRP (30 nM) in the presence of the DPCPX (10 nM) had been observed. Under these conditions, CGRP (30 nM) increased the ®eld EPSP slope by 18+5.4% (n=4, P50.05) and ZM 241385 (10 nM) was unable to reverse this excitatory eect of the neuropeptide. (Figure 3B ).
To further evaluate how A 2A receptor activation by endogenous adenosine was needed for the enhancement of synaptic transmission caused by CGRP upon A 1 receptor blockade, experiments were designed to test the in¯uence of adenosine deaminase, an enzyme that inactivates extracellular adenosine into inosine, in that action of CGRP. Adenosine deaminase (2 U ml 71 ) was applied to hippocampal slices in the presence of DPCPX (10 nM) and, as expected from the lack of eect of the A 2A antagonist on ®eld EPSPs, the enzyme was also virtually devoid of eect (per cent change of ®eld EPSP slope: 72.5+2.3%, n=4, after 20 min application) on ®eld EPSP slope. In these slices, the subsequent application of CGRP (30 nM) did not appreciable aect the ®eld EPSPs (per cent change of the slope: 1.3%+2.4, n=4). As expected, in parallel slices from Adenosine receptors and CGRP in the hippocampusthe same hippocampus, GCRP (30 nM) applied in the presence of DPCPX (10 nM Ribeiro, 1992; Li & Henry, 1998) .
As illustrated in Figure 4A , CGRP (30 nM) caused a marked and reversible increase in the slope of the ®eld EPSPs when applied to hippocampal slices in the presence of the A 2A agonist, CGS 21680 (10 nM). The facilitation of synaptic transmission caused by CGRP (3 ± 30 nM) in the presence of CGS 21680 (10 nM) was concentration-dependent ( Figure 4B ), 30 nM CGRP increasing the slope of the ®eld EPSPs by 36+8.2% (n=5, P50.05), an eect which is signi®cantly larger (P50.05) than that observed in other experiments using the same concentration of CGRP but in the presence of 10 nM DPCPX (17+1.3%, n=19). Interestingly, the ability of the A 2A agonist to unmask the facilitatory eect of CGRP on synaptic transmission does not appear to depend on its ability to facilitate synaptic transmission, since in the hippocampal slices where CGS 21680 (10 nM) did not increase the ®eld EPSP slope, CGRP (3 ± 30 nM) applied in the presence of CGS 21680 did facilitate synaptic transmission.
In¯uence of PK-A blockade or K ATP channels blockade on the eect of CGRP on synaptic transmission
To evaluate the in¯uence of the activity of protein kinase-A (PK-A) on the eect of CGRP we tested whether HA-1004 or RpcAMPS, two PK-A inhibitors (Hidaka & Kobayashi, 1992; Rothermel & Parker-Bothelho, 1998) , aected the ability of CGRP to enhance the slope of ®eld EPSPs. When applied to hippocampal slices in the presence of DPCPX (10 nM), neither HA-1004 (10 mM) nor RpcAMPS (50 mM) caused appreciable changes in the slope of the ®eld EPSPs (per cent change: 73.5+3.2%, n=5, for HA-1004 and 72.4+4.7%, n=3, for RpcAMPS); however, the subsequent application of CGRP (30 nM) to these slices failed to increase the slope of the ®eld EPSPs (1.8+1.7%, n=5, in the HA-1004 experiments, and 70.76+3.2%, n=3, in the RpcAMPS experiments). As illustrated in Figure 5 , CGRP (30 nM) increased the slope of the ®eld EPSPs (16+1.4%, n=6, P50.05) when applied to parallel slices in the presence of DPCPX (10 nM) but in the absence of the PK-A inhibitors. In Figure 5 is also illustrated the ability of the inhibitor of ATP dependent potassium channels (K ATP channels), glibenclamide, to prevent the excitatory eect of CGRP on synaptic transmission. By itself, and when applied to hippocampal slices in the presence of DPCPX (10 nM), glibenclamide (30 mM) caused a decrease (15+4.9%, n=7, P50.05) of the slope of the ®eld EPSPs. In six experiments using glibenclamide (30 mM) plus DPCPX (10 nM), CGRP (30 nM) failed to modify the EPSP slope in the presence of glibenclamide (per cent change: 1.7+0.7%) but increased EPSP slope (17+5%) in the absence of the K ATP channels inhibitor.
Discussion
To observe an exciatory action of CGRP on synaptic transmission in the CA1 area of the hippocampus it was necessary to block A 1 adenosine receptors with its selective antagonist, DPCPX or to activate A 2A adenosine receptors with its selective agonist, CGS 21680. The enhancement of synaptic transmission caused by CGRP upon blockade of A 1 adenosine receptors requires activation of excitatory A 2A adenosine receptors by endogenous adenosine, since the selective A 2A receptor antagonist ZM 241385, or adenosine deaminase, applied before CGRP, could prevent the facilitatory eect of this neuropeptide. Interestingly, when applied after the full eect of CGRP, ZM 241385 was unable to revert the excitatory action of the neuropeptide. This precludes the remote possibility that the A 2A agonist was directly interfering with the CGRP receptors and suggests that tonic activation of A 2A adenosine receptors is required for the induction but not for the maintenance of the excitatory action of CGRP on hippocampal synaptic transmission.
The ability of DPCPX and of CGS 21680 to trigger an excitatory action of CGRP on synaptic transmission in the hippocampus does probably not result solely from their facilitatory action on synaptic transmission, since (1) the simultaneous perfusion of DPCPX and ZM 241385 also caused an increase in the ®eld EPSP slope but, under these conditions, CGRP was unable to facilitate synaptic transmission and (2) CGS 21680 was able to trigger an excitatory action of CGRP even in the experiments where the A 2A agonist was unable to facilitate synaptic transmission.
A schematic diagram of the probable interplay between CGRP and A 1 or A 2A receptors is represented in Figure 6 . It is known that the main tonus of endogenous adenosine in the hippocampus, at least in the experimental conditions used, is inhibitory (e.g. Dunwiddie & Diao, 1994; Cunha et al., 1996) . Thus, the absence of eect of CGRP alone and its eect in the presence of DPCPX are highly suggestive that endogenous adenosine, by activating A 1 receptors, is tonically restraining the action of CGRP. Relieve of this inhibition by DPCPX allows the initiation of the action of CGRP providing that the A 2A receptors are operative to be activated by endogenous adenosine. Instead of blockade of A 1 receptors, activation of The eect of CGRP was tested ®rst in the absence (upper panel), than in the presence of HA-1004 (middle panel) or glibenclamide (lower panel). The adenosine A 1 receptor antagonist, DPCPX (10 nM) was present throughout the experiment. In this experiment, the per cent modi®cation of the ®eld EPSP slope caused by HA-1004 (10 mM) and glibenclamide (30 mM) was 70.5% and 76%, respectively. Figure 6 Schematic diagram of the model proposed for the interactions between adenosine (ADO) and CGRP in the hippocampus. Tonic activation of A 1 adenosine receptors by endogenous adenosine is indicated by the double arrow. An inhibitory interaction is indicated by (7) and a facilitatory interaction is indicated by (+).
A 2A receptors with its agonist, CGS 21680, was also able to trigger an excitatory action of CGRP on synaptic transmission. It is known that A 2A adenosine receptor activation by CGS 21680 inhibits A 1 receptor functioning in the hippocampus (Cunha et al., 1994) . Thus, the A 1 adenosine receptors are less operative in the presence of CGS 21680 and this may contribute to the ability of the A 2A agonist to trigger the facilitatory action of CGRP on synaptic transmission. However, this A 2A /A 1 adenosine receptor interaction is probably not the only mechanism by which A 2A receptor activation induces the ability of CGRP to enhance synaptic transmission, since the eect of this neuropeptide was greater in the presence of the A 2A agonist, CGS 21680, than in the presence of the A 1 antagonist, DPCPX.
CGRP receptors are positively coupled to adenylate cyclase in a variety of tissues (for a review see Wimalawansa, 1996) , and evidence has been provided that stimulation of adenylate cyclase, increased production and accumulation of cyclic AMP, and activation of PK-A, mediates activation of K ATP channels by GCRP (Wellman et al., 1998) . The present observations that the excitatory action of CGRP on synaptic transmission is prevented by inhibitiors of PK-A, as well as by a K ATP channel blocker, is also consistent with an involvement of PK-A and K ATP channels in the action of CGRP in the hippocampus. A 2A adenosine receptors are in most cases positively coupled to adenylate cyclase (see SebastiaÄ o & Ribeiro, 1996) . It is conceivable that A 2A receptor activation, by causing local enhancement of cyclic AMP levels, acts as a primer of the transducing system operated by CGRP in the hippocampus, which might explain the presently observed positive interaction between A 2A receptors activation and the action of CGRP on synaptic transmission.
The predominant inhibitory tonus by endogenous adenosine in the hippocampus (Dunwiddie & Diao, 1994) , might explain why CGRP by itself is unable to aect synaptic transmission. This contrasts with what occurs at motor nerve terminals, where endogenous adenosine tonically activates A 2A receptors (Correia-de-SaÂ et al., 1996) , and CGRP by itself facilitates neurotransmitter release (Correia-de-SaÂ & Ribeiro, 1994) . Interestingly, as it occurs in the hippocampus (present results), blockade of A 2A receptors prevents the facilitatory action of CGRP at motor nerve terminals (Correia-de-SaÂ & Ribeiro, 1994) .
In conclusion, the results presented in this paper show that the ability of CGRP to facilitate synaptic transmission in the CA1 area of the hippocampus is under tight control by adenosine, with the A 1 receptors`braking' the action of CGRP and the A 2A receptors`triggering' this action. The need of A 2A receptor activation by endogenous adenosine to reveal the excitatory action of CGRP on synaptic transmission in the hippocampus, taken together with the observation that the induction of the excitatory action of CGRP on synaptic transmission caused by CGS 21680 was more evident and consistent than the enhancement of synaptic transmission caused by the A 2A receptor agonist itself, suggests that a main role A 2A adenosine receptors in the hippocampus is to modulate the action of other neuromodulators and, by this process, to contribute for a sophisticated`®ne tune' of hippocampal functioning.
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